BEAR Virtual drug screening

Back to news

Date Posted: 16/10/2018
Publisher: BiPconnect

In silico virtual screening (or VS) greatly reduces the burden of high-throughput screening of large compound libraries. However, conventional VS such as docking usually depends on the structural information of both target proteins and their ligands, and its predictive accuracy is not yet sufficiently suitable for practical application in drug discovery. For more information, please click here.

Translate Into English   /   Revert to Original